drugset

drugset / Trial / NCT00568412

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

NCT00568412 ↗

Phase 4 Completed 80 enrolled Bayer

RandomizedParallel-groupDouble-blindTreatment

Summary

To show therapeutic efficacy of Zarzenda cream compared to Elidel cream in children and adolescents with mild to moderate atopic dermatitis

Timeline

Start: 2007-12
Primary completion: 2008-09
Completion: 2008-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Pimecrolimus	Small molecule	1 %	Topical

Indications